11hon MSN
As legal battles are fought over an executive order restricting transgender care for patients younger than 19, some clinics ...
Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results